NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 3 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253 | -99.9% | 20,500 | -48.3% | 0.00% | 0.0% |
| Q2 2022 | $323,000 | +13.7% | 39,626 | +69.7% | 0.00% | 0.0% |
| Q1 2022 | $284,000 | -76.2% | 23,347 | -33.2% | 0.00% | -66.7% |
| Q4 2021 | $1,193,000 | -29.2% | 34,938 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $1,685,000 | +33.6% | 34,938 | +25.2% | 0.01% | +12.5% |
| Q2 2021 | $1,261,000 | -3.5% | 27,911 | +3.0% | 0.01% | -11.1% |
| Q1 2021 | $1,307,000 | -11.1% | 27,106 | -0.8% | 0.01% | -10.0% |
| Q4 2020 | $1,471,000 | +49.2% | 27,313 | +2.2% | 0.01% | +42.9% |
| Q3 2020 | $986,000 | +5089.5% | 26,722 | +4331.5% | 0.01% | – |
| Q2 2020 | $19,000 | – | 603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |